Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet Dentalklinikken NØRREBRO ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   2.6% 1.9% 1.5% 2.1% 1.9% 1.6% 10.1% 9.9%   Credit score (0-100)   62 70 75 67 69 75 24 25   Credit rating   BBB A A A A A BB BB   Credit limit (kDKK)   0.0 1.3 26.7 0.6 2.8 32.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   6,354 6,975 6,458 9,046 10,266 9,673 0.0 0.0   EBITDA   1,425 1,985 2,145 2,315 2,680 2,095 0.0 0.0   EBIT   1,211 1,765 1,968 2,164 2,656 2,082 0.0 0.0   Pre-tax profit (PTP)   1,199.3 1,761.1 1,960.4 2,159.0 2,659.8 2,073.9 0.0 0.0   Net earnings   935.3 1,373.6 1,528.9 1,683.1 2,074.6 1,617.5 0.0 0.0   Pre-tax profit without non-rec. items   1,199 1,761 1,960 2,159 2,660 2,074 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   127 89.9 58.6 37.9 24.2 10.5 0.0 0.0   Shareholders equity total   1,976 3,350 4,879 6,562 8,636 10,254 2,329 2,329   Interest-bearing liabilities   270 0.0 0.0 0.0 0.0 1,264 0.0 0.0   Balance sheet total (assets)   3,201 5,462 7,142 8,610 11,330 13,676 2,329 2,329   Net Debt   175 -238 -350 -75.3 -90.5 1,221 -2,329 -2,329     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   6,354 6,975 6,458 9,046 10,266 9,673 0.0 0.0   Gross profit growth   2.9% 9.8% -7.4% 40.1% 13.5% -5.8% -100.0% 0.0%   Employees   10 9 9 15 13 14 0 0   Employee growth %   -9.1% -10.0% 0.0% 66.7% -13.3% 7.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,201 5,462 7,142 8,610 11,330 13,676 2,329 2,329   Balance sheet change%   -19.9% 70.7% 30.8% 20.6% 31.6% 20.7% -83.0% 0.0%   Added value   1,425.3 1,985.3 2,144.6 2,315.0 2,806.7 2,095.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -429 -388 -338 -302 -49 -27 -11 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   19.1% 25.3% 30.5% 23.9% 25.9% 21.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   33.7% 40.7% 31.2% 27.5% 26.7% 16.7% 0.0% 0.0%   ROI %   52.9% 61.3% 47.6% 37.8% 35.0% 20.7% 0.0% 0.0%   ROE %   62.0% 51.6% 37.2% 29.4% 27.3% 17.1% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   64.5% 63.4% 70.8% 77.5% 77.4% 75.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   12.3% -12.0% -16.3% -3.3% -3.4% 58.3% 0.0% 0.0%   Gearing %   13.6% 0.0% 0.0% 0.0% 0.0% 12.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.8% 2.6% 0.0% 0.0% 0.0% 2.4% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   3.1 3.5 4.5 5.9 5.8 4.7 0.0 0.0   Current Ratio   2.7 3.1 3.8 5.4 5.3 4.6 0.0 0.0   Cash and cash equivalent   94.4 237.8 349.5 75.3 90.5 43.3 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,609.5 3,393.7 5,049.7 6,871.2 9,058.0 10,570.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   143 221 238 154 216 150 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   143 221 238 154 206 150 0 0   EBIT / employee   121 196 219 144 204 149 0 0   Net earnings / employee   94 153 170 112 160 116 0 0